发明公开
EP2207874A4 ENGINEERED DENDRITIC CELLS AND USES FOR THE TREATMENT OF CANCER
有权
技术手册DENDRITISCHE ZELLEN UND VERWENDUNGEN ZUR KREBSBEHANDLUNG
- 专利标题： ENGINEERED DENDRITIC CELLS AND USES FOR THE TREATMENT OF CANCER
- 专利标题（中）： 技术手册DENDRITISCHE ZELLEN UND VERWENDUNGEN ZUR KREBSBEHANDLUNG
-
申请号： EP08836827申请日： 2008-10-08
-
公开(公告)号： EP2207874A4公开(公告)日： 2010-11-10
- 发明人: BRAUGHLER J MARK , KUMAR PRASANNA , STORKUS WALTER J , OKADA HIDEHO
- 申请人： INTREXON CORP , UNIV PITTBURGH OF THE COMMONWE
- 专利权人： INTREXON CORP,UNIV PITTBURGH OF THE COMMONWE
- 当前专利权人： INTREXON CORP,UNIV PITTBURGH OF THE COMMONWE
- 优先权： US97822407 2007-10-08; US97839407 2007-10-08; US97850907 2007-10-09; US97948507 2007-10-12; US97948007 2007-10-12; US99016707 2007-11-26; US99068907 2007-11-28; US99180707 2007-12-03; US1908908 2008-01-04
- 主分类号： C12N5/00
- IPC分类号： C12N5/00 ; C12N5/02 ; C12N5/0784 ; C12N15/00
摘要：
This invention provides the field of therapeutics. Most specifically present invention provides methods of generating in vitro engineered dendritic cells conditionally expressing interleukin-12 (IL- 12) under the control of a gene expression modulation system in the presence of activating ligand and uses for therapeutic purposes in animals including human.
信息查询
